158 related articles for article (PubMed ID: 23876211)
1. Effects of angiotensin II type 1 receptor blocker and adiponectin on adipocyte dysfunction in stroke-prone spontaneously hypertensive rats.
Takemori K; Inoue T; Ito H
Lipids Health Dis; 2013 Jul; 12():108. PubMed ID: 23876211
[TBL] [Abstract][Full Text] [Related]
2. Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.
Zorad S; Dou JT; Benicky J; Hutanu D; Tybitanclova K; Zhou J; Saavedra JM
Eur J Pharmacol; 2006 Dec; 552(1-3):112-22. PubMed ID: 17064684
[TBL] [Abstract][Full Text] [Related]
3. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
[TBL] [Abstract][Full Text] [Related]
4. Candesartan-induced gene expression in five organs of stroke-prone spontaneously hypertensive rats.
Kato N; Liang YQ; Ochiai Y; Birukawa N; Serizawa M; Jesmin S
Hypertens Res; 2008 Oct; 31(10):1963-75. PubMed ID: 19015604
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
Inada Y; Wada T; Ojima M; Sanada T; Shibouta Y; Kanagawa R; Ishimura Y; Fujisawa Y; Nishikawa K
Clin Exp Hypertens; 1997 Oct; 19(7):1079-99. PubMed ID: 9310205
[TBL] [Abstract][Full Text] [Related]
6. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
Obata J; Nakamura T; Takano H; Naito A; Kimura H; Yoshida Y; Shimizu F; Guo DF; Inagami T
J Hypertens; 2000 Sep; 18(9):1247-55. PubMed ID: 10994756
[TBL] [Abstract][Full Text] [Related]
7. Role of RAAS and adipokines in cardiovascular protection: effect of different doses of angiotensin II receptor blocker on adipokines level in hypertensive patients.
Hass A; Oz H; Mashavi M; Shargorodsky M
J Am Soc Hypertens; 2014 Oct; 8(10):709-14. PubMed ID: 25418492
[TBL] [Abstract][Full Text] [Related]
8. Superoxide dismutase mimetic, tempol, aggravates renal injury in advanced-stage stroke-prone spontaneously hypertensive rats.
Sugama I; Kohagura K; Yamazato M; Nakamura T; Shinzato T; Ohya Y
J Hypertens; 2014 Mar; 32(3):534-41. PubMed ID: 24309490
[TBL] [Abstract][Full Text] [Related]
9. Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats.
Obata J; Nakamura T; Kuroyanagi R; Yoshida Y; Guo DF; Inagami T
Kidney Int Suppl; 1997 Dec; 63():S229-31. PubMed ID: 9407467
[TBL] [Abstract][Full Text] [Related]
10. Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats.
Kim-Mitsuyama S; Yamamoto E; Tanaka T; Zhan Y; Izumi Y; Izumiya Y; Ioroi T; Wanibuchi H; Iwao H
Stroke; 2005 May; 36(5):1083-8. PubMed ID: 15817892
[TBL] [Abstract][Full Text] [Related]
11. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats.
Takemori K; Ishida H; Ito H
Life Sci; 2005 Sep; 77(18):2233-45. PubMed ID: 15963533
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan.
Nakamura T; Yamamoto E; Kataoka K; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ogawa H; Kim-Mitsuyama S
Hypertension; 2008 Feb; 51(2):296-301. PubMed ID: 18158350
[TBL] [Abstract][Full Text] [Related]
13. Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade.
Camargo MJ; von Lutterotti N; Campbell WG; Pecker MS; James GD; Timmermans PB; Laragh JH
J Hypertens; 1993 Jan; 11(1):31-40. PubMed ID: 8382237
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of combination of perindopril, candesartan, and amlodipine in hypertensive rats.
Kim S; Zhan Y; Izumi Y; Iwao H
Hypertension; 2000 Mar; 35(3):769-74. PubMed ID: 10720593
[TBL] [Abstract][Full Text] [Related]
15. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
[TBL] [Abstract][Full Text] [Related]
16. Hypotensive and prophylactic effects of angiotensin II subtype 1 receptor antagonist, irbesartan, in stroke-prone spontaneously hypertensive rats.
Shimamura T; Masui M; Torii M; Nakajima M
Clin Exp Hypertens; 2004 Jan; 26(1):27-42. PubMed ID: 15000295
[TBL] [Abstract][Full Text] [Related]
17. Telmisartan but not candesartan affects adiponectin expression in vivo and in vitro.
Yamada S; Ano N; Toda K; Kitaoka A; Shiono K; Inoue G; Atsuda K; Irie J
Hypertens Res; 2008 Apr; 31(4):601-6. PubMed ID: 18633170
[TBL] [Abstract][Full Text] [Related]
18. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
[TBL] [Abstract][Full Text] [Related]
19. Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
Naruse M; Tanabe A; Hara Y; Takagi S; Imaki T; Takano K
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S1-3. PubMed ID: 15838251
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke.
Saad MA; Abbas AM; Boshra V; Elkhateeb M; El Aal IA
Acta Physiol Hung; 2010 Jun; 97(2):159-71. PubMed ID: 20511125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]